Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia

Author： Schneider Vanessa Egenrieder Stephanie Götz Marlies Herbst Cornelia Greiner Jochen Hofmann Susanne

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.7, 2013-07, pp. : 1500-1504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A novel compound against oncogenic Aurora kinase A overcomes imatinib resistance in chronic myeloid leukemia cells

International Journal of Oncology, Vol. 46, Iss. 6, 2015-01 ,pp. : 2488-2496

Spandidos Publications

Access to resources Recommend Favorite

Tyrosine kinase inhibition in acute myeloid leukemia

By Altman Jessica K. Szilard Amy K. Platanias Leonidas C.

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1351-1352

Informa Healthcare

Access to resources Recommend Favorite

Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 31-49

Bentham Science Publishers

Access to resources Recommend Favorite

Combined immunophenotyping and fluorescence in situ hybridization with chromosome-specific DNA probes allows quantification and differentiation of ex vivo generated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia

By Kremser Andreas

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1297-1308

Informa Healthcare

Access to resources Recommend Favorite

Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells

By Jayanthan Aarthi

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1505-1516

Informa Healthcare

Access to resources Recommend Favorite